Skip to main content
SpringerLink
Log in

Off-label treatment with Pasireotide and use of continuous glucose monitoring in late familial hyperinsulinemic hypoglycemia: a case report

  • Case Report
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hojlund K, Hansen T, Lajer M, Henriksen JE, Levin K, Lindholm J, Pedersen O, Beck-Nielsen H (2004) A novel syndrome of autosomal-dominant hyperinsulinemic hypoglycemia linked to a mutation in the human insulin receptor gene. Diabetes 53:1592–1598

    Article  CAS  Google Scholar 

  2. Silverstein JM (2016) Hyperglycemia induced by pasireotide in patients with Cushing’s disease or acromegaly. Pituitary 19:536–543

    Article  CAS  Google Scholar 

  3. Ohrstrom CC, Hansen DL, Kielgast UL, Hartmann B, Holst JJ, Worm D (2020) A Low dose of pasireotide prevents hypoglycemia in Roux-en-Y gastric bypass-operated individuals. Obes Surg 30:1605–1610

    Article  Google Scholar 

  4. Sileo F, Cangiano B, Cacciatore C, Amaru J, Gatto F, Albertelli M, Falconi M, Vitale G, Persani L (2020) Off-label pasireotide treatment in one insulinoma patient with an atypical presentation and intolerant to diazoxide. Endocrine 70:435–438

    Article  CAS  Google Scholar 

  5. https://www.dexcom.com/g6-cgm-system. Accessed on March 31st 2021.

Download references

Acknowledgements

U. Feldt-Rasmussen’s research salary was sponsored by The Kirsten and Freddy Johansen’s Fund. L. Ringholm has received a research grant from Novo Nordisk (Grant number: U1111-1209-6358) for an investigator sponsored study.

Funding

None.

Author information

Authors and Affiliations

  1. Department of Medical Endocrinology and Metabolism PE7562, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark

    Suresha U. Muthunayake, Ulla Feldt-Rasmussen & Lene Ringholm

  2. Institute of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark

    Ulla Feldt-Rasmussen

Authors
  1. Suresha U. Muthunayake
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ulla Feldt-Rasmussen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lene Ringholm
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lene Ringholm.

Ethics declarations

Conflicts of interest

S. U. Muthunayake, U. Feldt-Rasmussen and L. Ringholm declare that they have no conflicts of interests.

Informed consent

Written informed consent for publication of the clinical details was obtained from the patient. A copy of the consent form is available for review by the Editor of this journal.

Additional information

Managed by Massimo Porta .

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Muthunayake, S.U., Feldt-Rasmussen, U. & Ringholm, L. Off-label treatment with Pasireotide and use of continuous glucose monitoring in late familial hyperinsulinemic hypoglycemia: a case report. Acta Diabetol 58, 1123–1125 (2021). https://doi.org/10.1007/s00592-021-01723-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-021-01723-9

Search

Navigation